Breast cancer death rates are similar in BRCA mutation carriers and noncarriers
This article has no abstract so we have provided the first paragraph of the full text.
BRCA1-associated breast cancers are characterized by features that are associated with a poor prognosis; however, the effect of BRCA1 or BRCA2 mutations on prognosis remains unclear. A recent study by Rennert et al. compared the survival rates of breast cancer patients with and without a BRCA1 or BRCA2 mutation.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.